MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-γ challenge

Horwitz, 2002, Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone, Proc Natl Acad Sci U S A, 99, 8932, 10.1073/pnas.132252399 Horwitz, 1999, Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta, Nat Med, 5, 309, 10.1038/6529 Spaggiari, 2006, Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, 107, 1484, 10.1182/blood-2005-07-2775 Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182/blood-2005-07-2657 Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp Cell Res, 305, 33, 10.1016/j.yexcr.2004.12.013 Jiang, 2005, Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells, Blood, 105, 4120, 10.1182/blood-2004-02-0586 Rasmusson, 2003, Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells, Transplantation, 76, 1208, 10.1097/01.TP.0000082540.43730.80 Angelopoulou, 2003, Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice, Exp Hematol, 31, 413, 10.1016/S0301-472X(03)00042-0 Bartholomew, 2002, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp Hematol, 30, 42, 10.1016/S0301-472X(01)00769-X Chan, 2006, Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma, Blood, 107, 4817, 10.1182/blood-2006-01-0057 Stagg, 2006, Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell, Blood, 107, 2570, 10.1182/blood-2005-07-2793 Le Blanc, 2003, HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, Exp Hematol, 31, 890, 10.1016/S0301-472X(03)00110-3 Buttice, 2006, Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells, Circ Res, 98, 472, 10.1161/01.RES.0000204725.46332.97 Ilangumaran, 2002, A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts, J Immunol, 169, 5010, 10.4049/jimmunol.169.9.5010 Platanias, 2005, Mechanisms of type-I- and type-II-interferon-mediated signalling, Nat Rev Immunol, 5, 375, 10.1038/nri1604 Piskurich, 1999, Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor 1, and transforming growth factor beta, Mol Cell Biol, 19, 431, 10.1128/MCB.19.1.431 Wright, 2006, Epigenetic regulation of MHC-II and CIITA genes, Trends Immunol, 27, 405, 10.1016/j.it.2006.07.007 Chang, 1994, Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes, J Exp Med, 180, 1367, 10.1084/jem.180.4.1367 Yeung, 1996, An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells, Proc Natl Acad Sci U S A, 93, 12451, 10.1073/pnas.93.22.12451 Mullan, 2005, The 2,5 oligoadenylate synthetase/RNaseL pathway is a novel effector of BRCA1- and interferon-gamma-mediated apoptosis, Oncogene, 24, 5492, 10.1038/sj.onc.1208698 Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559 Beyth, 2005, Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness, Blood, 105, 2214, 10.1182/blood-2004-07-2921 Di Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838 Groh, 2005, Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells, Exp Hematol, 33, 928, 10.1016/j.exphem.2005.05.002 Tse, 2003, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation, 75, 389, 10.1097/01.TP.0000045055.63901.A9 Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation, Blood, 103, 4619, 10.1182/blood-2003-11-3909 Nasef, 2007, Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G, Transplantation, 84, 231, 10.1097/01.tp.0000267918.07906.08 Eliopoulos, 2005, Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice, Blood, 106, 4057, 10.1182/blood-2005-03-1004 Li, 2004, Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents, Br J Haematol, 127, 326, 10.1111/j.1365-2141.2004.05200.x Romieu-Mourez, 2007, Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density, J Immunol, 179, 1549, 10.4049/jimmunol.179.3.1549 Tang, 2008, Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA, J Immunol, 180, 1826, 10.4049/jimmunol.180.3.1826 Lau, 1986, Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy, J Clin Invest, 77, 1632, 10.1172/JCI112480 Wagner, 2007, Mesenchymal stem cell preparations-comparing apples and oranges, Stem Cell Rev, 3, 239, 10.1007/s12015-007-9001-1 Le Blanc, 2004, Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes, Scand J Immunol, 60, 307, 10.1111/j.0300-9475.2004.01483.x Krampera, 2006, Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells, Stem Cells, 24, 386, 10.1634/stemcells.2005-0008 Fang, 2006, Sensitive balance of suppressing and activating effects of mesenchymal stem cells on T-cell proliferation, Transplantation, 82, 1370, 10.1097/01.tp.0000232450.62408.f9 Klyushnenkova, 2005, T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression, J Biomed Sci, 12, 47, 10.1007/s11373-004-8183-7 Plumas, 2005, Mesenchymal stem cells induce apoptosis of activated T cells, Leukemia, 19, 1597, 10.1038/sj.leu.2403871